98.24
price up icon0.64%   0.62
after-market Dopo l'orario di chiusura: 98.24
loading
Precedente Chiudi:
$97.62
Aprire:
$97.76
Volume 24 ore:
3.34M
Relative Volume:
1.18
Capitalizzazione di mercato:
$17.27B
Reddito:
$381.03M
Utile/perdita netta:
$-1.01B
Rapporto P/E:
-16.51
EPS:
-5.95
Flusso di cassa netto:
$-789.25M
1 W Prestazione:
-6.30%
1M Prestazione:
+37.05%
6M Prestazione:
+40.44%
1 anno Prestazione:
+52.31%
Intervallo 1D:
Value
$96.65
$98.38
Intervallo di 1 settimana:
Value
$96.65
$105.80
Portata 52W:
Value
$60.40
$106.83

Insmed Inc Stock (INSM) Company Profile

Name
Nome
Insmed Inc
Name
Telefono
908-977-9900
Name
Indirizzo
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Name
Dipendente
1,271
Name
Cinguettio
@insmed
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
INSM's Discussions on Twitter

Confronta INSM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
INSM
Insmed Inc
98.24 17.27B 381.03M -1.01B -789.25M -5.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Insmed Inc Stock (INSM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-13 Iniziato Jefferies Buy
2025-02-25 Iniziato RBC Capital Mkts Outperform
2024-04-23 Iniziato Truist Buy
2024-02-15 Iniziato Wolfe Research Outperform
2023-12-08 Iniziato Wells Fargo Overweight
2023-11-20 Ripresa JP Morgan Overweight
2023-07-26 Iniziato Guggenheim Buy
2022-12-09 Iniziato Mizuho Buy
2022-12-07 Iniziato Barclays Overweight
2022-11-18 Iniziato BofA Securities Buy
2022-04-27 Iniziato Goldman Buy
2021-12-06 Iniziato JP Morgan Overweight
2021-10-19 Ripresa Monness Crespi & Hardt Buy
2021-10-19 Ripresa Morgan Stanley Overweight
2021-10-08 Iniziato Cantor Fitzgerald Overweight
2021-04-26 Ripresa Credit Suisse Outperform
2020-12-17 Iniziato Berenberg Buy
2020-10-12 Ripresa Stifel Buy
2019-09-03 Iniziato Goldman Buy
2019-04-09 Reiterato H.C. Wainwright Buy
2019-02-15 Aggiornamento JMP Securities Mkt Perform → Mkt Outperform
2019-01-17 Aggiornamento Goldman Neutral → Buy
2019-01-02 Iniziato Canaccord Genuity Buy
2018-08-06 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2018-07-23 Iniziato Goldman Neutral
2018-04-23 Aggiornamento Credit Suisse Neutral → Outperform
2018-03-21 Iniziato Morgan Stanley Overweight
2018-01-18 Iniziato Credit Suisse Neutral
2017-09-05 Reiterato Evercore ISI Outperform
2017-08-17 Iniziato Evercore ISI Outperform
2017-07-11 Iniziato Robert W. Baird Outperform
2016-03-15 Iniziato Stifel Buy
2015-11-09 Downgrade UBS Buy → Neutral
2015-10-06 Reiterato H.C. Wainwright Buy
2015-06-09 Iniziato Citigroup Neutral
2014-03-26 Reiterato HC Wainwright Buy
Mostra tutto

Insmed Inc Borsa (INSM) Ultime notizie

pulisher
Jun 18, 2025

Insider Sell: Roger Adsett Sells 10,686 Shares of Insmed Inc (INSM) - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Mizuho Reiterates Outperform Rating on Insmed (INSM), Boosts PT to $110 - Insider Monkey

Jun 18, 2025
pulisher
Jun 17, 2025

10 Best Growth Stocks to Buy According to Billionaires - Insider Monkey

Jun 17, 2025
pulisher
Jun 17, 2025

Wells Fargo Lifts Price Target on Insmed Incorporated (INSM) to $119 From $107 - Insider Monkey

Jun 17, 2025
pulisher
Jun 17, 2025

Is Insmed Stock Overvalued at $98? - Nasdaq

Jun 17, 2025
pulisher
Jun 17, 2025

Goldman Sachs Hikes Insmed (INSM) Price Target to $112 Affirms Buy Rating - Insider Monkey

Jun 17, 2025
pulisher
Jun 16, 2025

Insmed Completes $750 Million Follow-On Public Offering - Global Legal Chronicle

Jun 16, 2025
pulisher
Jun 16, 2025

Is Insmed Stock Overvalued After The 45% Jump? - Forbes

Jun 16, 2025
pulisher
Jun 15, 2025

Oracle, AST SpaceMobile And Halliburton Are Among Top 10 Large Cap Gainers Last Week (June 9-13): Are The Others In Your Portfolio? - Benzinga

Jun 15, 2025
pulisher
Jun 15, 2025

Insmed Inc (INSM) Soars 30% on Impressive Study - MSN

Jun 15, 2025
pulisher
Jun 13, 2025

Insmed Incorporated (INSM) Soars on Positive PAH Therapy Trial Results - Insider Monkey

Jun 13, 2025
pulisher
Jun 13, 2025

INSM September 19th Options Begin Trading - Nasdaq

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans - Yahoo Finance

Jun 13, 2025
pulisher
Jun 12, 2025

Insmed (INSM) Soars After Raising $650 million - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed Stock Jumps 29% on Encouraging PAH Study Results - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Finance Watch: Insmed Cashes In On Positive Data With $750m Offering - insights.citeline.com

Jun 12, 2025
pulisher
Jun 12, 2025

SEC Form 424B5 filed by Insmed Incorporated - Quantisnow

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed prices capital raise of $750 via stock offering - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed announces $650M public offering of common stock - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed Stock Ends Volatile Session Lower, Pauses After Monumental 32% Weekly Surge - Daily Chhattisgarh News

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed aims to raise $750M in one of the largest stock offerings this year - Endpoints News

Jun 12, 2025
pulisher
Jun 12, 2025

Stocks To Watch: Insmed Sees RS Rating Jump To 93 - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed dips after $750 mln stock sale - TradingView

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed (INSM) Secures $750 Million Through Stock Offering - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed is an attractive, but expensive takeout meal - statnews.com

Jun 12, 2025
pulisher
Jun 12, 2025

INSM Increases Common Stock Offering to $750M | INSM Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed Prices $750 Million Common Stock Offering - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Bank of America Issues Positive Forecast for Insmed (NASDAQ:INSM) Stock Price - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed Raises Massive $750M in Stock Offering to Advance Breakthrough Drug Pipeline - Stock Titan

Jun 12, 2025
pulisher
Jun 12, 2025

INSM: Mizuho Raises Price Target for Insmed to $110 | INSM Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 11, 2025

Insmed Prices Public Offering Of About 7.81 Mln Shares At $96.00/shr - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed raises $750 million in public offering of common stock By Investing.com - Investing.com Canada

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed Announces Pricing of $750 Million Public Offering of Comm - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed raises $750 million in public offering of common stock - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed Announces Pricing Of $750 Million Public Offering Of Common Stock At $96 Per Share - marketscreener.com

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed Announces Pricing of $750 Million Public Offering of Common Stock - marketscreener.com

Jun 11, 2025
pulisher
Jun 11, 2025

These 10 Stocks Are Flying High - Insider Monkey

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed (INSM) Plans $650M Public Offering of Common Stock | INSM - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed's drug for rare lung disease meets main goal in mid-stage trial - MSN

Jun 11, 2025
pulisher
Jun 11, 2025

Analyst Kelly Shi from Jefferies Maintained a Buy Rating on Insmed Incorporated (INSM) - Yahoo Finance

Jun 11, 2025
pulisher
Jun 11, 2025

$100 Invested In Insmed 10 Years Ago Would Be Worth This Much Today - Benzinga

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed (INSM) Sees Price Target Boost Amid Strong PAH Data | INS - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed (INSM) Price Target Raised to $120 by HC Wainwright & Co. - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed (INSM) Plans $650M Stock Offering, Shares Fall - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed announces $650 million public offering of common stock - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed announces $650 million public offering of common stock By Investing.com - Investing.com Canada

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed Plans $650 Million Public Offering - marketscreener.com

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed announces $650M common stock offering - TipRanks

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed Announces Proposed $650 Million Public Offering of Common Stock | INSM Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed (INSM) Sees Boost with Positive Phase 2b Trial Results | - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed (INSM) Receives Boosted Price Target from Wells Fargo | I - GuruFocus

Jun 11, 2025

Insmed Inc Azioni (INSM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Insmed Inc Azioni (INSM) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Bonstein Sara
Chief Financial Officer
Jun 23 '25
Option Exercise
19.16
47,889
917,479
151,301
Bonstein Sara
Chief Financial Officer
Jun 23 '25
Sale
101.78
57,765
5,879,089
93,536
$22.62
price up icon 6.70%
$36.19
price up icon 0.86%
$20.44
price down icon 1.45%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):